The global market for Pharmaceutical Formulation Development was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Pharmaceutical formulation development is the process of designing and developing a dosage form or drug product that contains the active pharmaceutical ingredient (API) in a suitable form for administration to patients. It involves the selection of appropriate excipients, development of a stable and effective formulation, and optimization of the manufacturing process.
The goal of formulation development is to ensure that the drug product is safe, effective, and of high quality. It involves various stages, including pre-formulation studies, formulation design, process development, and optimization. The formulation development team works closely with other departments, such as analytical development, regulatory affairs, and manufacturing, to ensure that the final product meets all the necessary requirements.
During the formulation development process, factors such as the physicochemical properties of the API, desired route of administration, patient population, and stability considerations are taken into account. Different dosage forms, such as tablets, capsules, liquids, creams, and injectables, may be developed depending on the specific requirements of the drug.
Formulation development also involves conducting stability studies to assess the shelf-life of the drug product under various storage conditions. This helps to ensure that the formulation remains stable and retains its potency and quality throughout its intended shelf-life.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Formulation Development, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Formulation Development.
The Pharmaceutical Formulation Development market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical Formulation Development market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Formulation Development companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
LGM Pharma
Dalton Pharma Services
Recipharm
Aurigene Pharmaceutical Services
Coriolis Pharma
Intertek
Quay Pharma
Lonza
Ardena
Kemwell
SGS
Syngene International
Piramal Pharma Solutions
Pharma Mo Ltd
Metrics Contract Services
COREALIS Pharma
Element Materials Technology
Adare Pharma Solutions
Singota Solutions
Creative Biolabs
Segment by Type
Oral
External Use
Segment by Application
Hospital
Enterprise
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Formulation Development company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Formulation Development Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oral
1.2.3 External Use
1.3 Market by Application
1.3.1 Global Pharmaceutical Formulation Development Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Enterprise
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Formulation Development Market Perspective (2020-2031)
2.2 Global Pharmaceutical Formulation Development Growth Trends by Region
2.2.1 Global Pharmaceutical Formulation Development Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pharmaceutical Formulation Development Historic Market Size by Region (2020-2025)
2.2.3 Pharmaceutical Formulation Development Forecasted Market Size by Region (2026-2031)
2.3 Pharmaceutical Formulation Development Market Dynamics
2.3.1 Pharmaceutical Formulation Development Industry Trends
2.3.2 Pharmaceutical Formulation Development Market Drivers
2.3.3 Pharmaceutical Formulation Development Market Challenges
2.3.4 Pharmaceutical Formulation Development Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Formulation Development Players by Revenue
3.1.1 Global Top Pharmaceutical Formulation Development Players by Revenue (2020-2025)
3.1.2 Global Pharmaceutical Formulation Development Revenue Market Share by Players (2020-2025)
3.2 Global Pharmaceutical Formulation Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pharmaceutical Formulation Development Revenue
3.4 Global Pharmaceutical Formulation Development Market Concentration Ratio
3.4.1 Global Pharmaceutical Formulation Development Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Formulation Development Revenue in 2024
3.5 Global Key Players of Pharmaceutical Formulation Development Head office and Area Served
3.6 Global Key Players of Pharmaceutical Formulation Development, Product and Application
3.7 Global Key Players of Pharmaceutical Formulation Development, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Formulation Development Breakdown Data by Type
4.1 Global Pharmaceutical Formulation Development Historic Market Size by Type (2020-2025)
4.2 Global Pharmaceutical Formulation Development Forecasted Market Size by Type (2026-2031)
5 Pharmaceutical Formulation Development Breakdown Data by Application
5.1 Global Pharmaceutical Formulation Development Historic Market Size by Application (2020-2025)
5.2 Global Pharmaceutical Formulation Development Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pharmaceutical Formulation Development Market Size (2020-2031)
6.2 North America Pharmaceutical Formulation Development Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pharmaceutical Formulation Development Market Size by Country (2020-2025)
6.4 North America Pharmaceutical Formulation Development Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Formulation Development Market Size (2020-2031)
7.2 Europe Pharmaceutical Formulation Development Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pharmaceutical Formulation Development Market Size by Country (2020-2025)
7.4 Europe Pharmaceutical Formulation Development Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Formulation Development Market Size (2020-2031)
8.2 Asia-Pacific Pharmaceutical Formulation Development Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pharmaceutical Formulation Development Market Size by Region (2020-2025)
8.4 Asia-Pacific Pharmaceutical Formulation Development Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical Formulation Development Market Size (2020-2031)
9.2 Latin America Pharmaceutical Formulation Development Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pharmaceutical Formulation Development Market Size by Country (2020-2025)
9.4 Latin America Pharmaceutical Formulation Development Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Formulation Development Market Size (2020-2031)
10.2 Middle East & Africa Pharmaceutical Formulation Development Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pharmaceutical Formulation Development Market Size by Country (2020-2025)
10.4 Middle East & Africa Pharmaceutical Formulation Development Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 LGM Pharma
11.1.1 LGM Pharma Company Details
11.1.2 LGM Pharma Business Overview
11.1.3 LGM Pharma Pharmaceutical Formulation Development Introduction
11.1.4 LGM Pharma Revenue in Pharmaceutical Formulation Development Business (2020-2025)
11.1.5 LGM Pharma Recent Development
11.2 Dalton Pharma Services
11.2.1 Dalton Pharma Services Company Details
11.2.2 Dalton Pharma Services Business Overview
11.2.3 Dalton Pharma Services Pharmaceutical Formulation Development Introduction
11.2.4 Dalton Pharma Services Revenue in Pharmaceutical Formulation Development Business (2020-2025)
11.2.5 Dalton Pharma Services Recent Development
11.3 Recipharm
11.3.1 Recipharm Company Details
11.3.2 Recipharm Business Overview
11.3.3 Recipharm Pharmaceutical Formulation Development Introduction
11.3.4 Recipharm Revenue in Pharmaceutical Formulation Development Business (2020-2025)
11.3.5 Recipharm Recent Development
11.4 Aurigene Pharmaceutical Services
11.4.1 Aurigene Pharmaceutical Services Company Details
11.4.2 Aurigene Pharmaceutical Services Business Overview
11.4.3 Aurigene Pharmaceutical Services Pharmaceutical Formulation Development Introduction
11.4.4 Aurigene Pharmaceutical Services Revenue in Pharmaceutical Formulation Development Business (2020-2025)
11.4.5 Aurigene Pharmaceutical Services Recent Development
11.5 Coriolis Pharma
11.5.1 Coriolis Pharma Company Details
11.5.2 Coriolis Pharma Business Overview
11.5.3 Coriolis Pharma Pharmaceutical Formulation Development Introduction
11.5.4 Coriolis Pharma Revenue in Pharmaceutical Formulation Development Business (2020-2025)
11.5.5 Coriolis Pharma Recent Development
11.6 Intertek
11.6.1 Intertek Company Details
11.6.2 Intertek Business Overview
11.6.3 Intertek Pharmaceutical Formulation Development Introduction
11.6.4 Intertek Revenue in Pharmaceutical Formulation Development Business (2020-2025)
11.6.5 Intertek Recent Development
11.7 Quay Pharma
11.7.1 Quay Pharma Company Details
11.7.2 Quay Pharma Business Overview
11.7.3 Quay Pharma Pharmaceutical Formulation Development Introduction
11.7.4 Quay Pharma Revenue in Pharmaceutical Formulation Development Business (2020-2025)
11.7.5 Quay Pharma Recent Development
11.8 Lonza
11.8.1 Lonza Company Details
11.8.2 Lonza Business Overview
11.8.3 Lonza Pharmaceutical Formulation Development Introduction
11.8.4 Lonza Revenue in Pharmaceutical Formulation Development Business (2020-2025)
11.8.5 Lonza Recent Development
11.9 Ardena
11.9.1 Ardena Company Details
11.9.2 Ardena Business Overview
11.9.3 Ardena Pharmaceutical Formulation Development Introduction
11.9.4 Ardena Revenue in Pharmaceutical Formulation Development Business (2020-2025)
11.9.5 Ardena Recent Development
11.10 Kemwell
11.10.1 Kemwell Company Details
11.10.2 Kemwell Business Overview
11.10.3 Kemwell Pharmaceutical Formulation Development Introduction
11.10.4 Kemwell Revenue in Pharmaceutical Formulation Development Business (2020-2025)
11.10.5 Kemwell Recent Development
11.11 SGS
11.11.1 SGS Company Details
11.11.2 SGS Business Overview
11.11.3 SGS Pharmaceutical Formulation Development Introduction
11.11.4 SGS Revenue in Pharmaceutical Formulation Development Business (2020-2025)
11.11.5 SGS Recent Development
11.12 Syngene International
11.12.1 Syngene International Company Details
11.12.2 Syngene International Business Overview
11.12.3 Syngene International Pharmaceutical Formulation Development Introduction
11.12.4 Syngene International Revenue in Pharmaceutical Formulation Development Business (2020-2025)
11.12.5 Syngene International Recent Development
11.13 Piramal Pharma Solutions
11.13.1 Piramal Pharma Solutions Company Details
11.13.2 Piramal Pharma Solutions Business Overview
11.13.3 Piramal Pharma Solutions Pharmaceutical Formulation Development Introduction
11.13.4 Piramal Pharma Solutions Revenue in Pharmaceutical Formulation Development Business (2020-2025)
11.13.5 Piramal Pharma Solutions Recent Development
11.14 Pharma Mo Ltd
11.14.1 Pharma Mo Ltd Company Details
11.14.2 Pharma Mo Ltd Business Overview
11.14.3 Pharma Mo Ltd Pharmaceutical Formulation Development Introduction
11.14.4 Pharma Mo Ltd Revenue in Pharmaceutical Formulation Development Business (2020-2025)
11.14.5 Pharma Mo Ltd Recent Development
11.15 Metrics Contract Services
11.15.1 Metrics Contract Services Company Details
11.15.2 Metrics Contract Services Business Overview
11.15.3 Metrics Contract Services Pharmaceutical Formulation Development Introduction
11.15.4 Metrics Contract Services Revenue in Pharmaceutical Formulation Development Business (2020-2025)
11.15.5 Metrics Contract Services Recent Development
11.16 COREALIS Pharma
11.16.1 COREALIS Pharma Company Details
11.16.2 COREALIS Pharma Business Overview
11.16.3 COREALIS Pharma Pharmaceutical Formulation Development Introduction
11.16.4 COREALIS Pharma Revenue in Pharmaceutical Formulation Development Business (2020-2025)
11.16.5 COREALIS Pharma Recent Development
11.17 Element Materials Technology
11.17.1 Element Materials Technology Company Details
11.17.2 Element Materials Technology Business Overview
11.17.3 Element Materials Technology Pharmaceutical Formulation Development Introduction
11.17.4 Element Materials Technology Revenue in Pharmaceutical Formulation Development Business (2020-2025)
11.17.5 Element Materials Technology Recent Development
11.18 Adare Pharma Solutions
11.18.1 Adare Pharma Solutions Company Details
11.18.2 Adare Pharma Solutions Business Overview
11.18.3 Adare Pharma Solutions Pharmaceutical Formulation Development Introduction
11.18.4 Adare Pharma Solutions Revenue in Pharmaceutical Formulation Development Business (2020-2025)
11.18.5 Adare Pharma Solutions Recent Development
11.19 Singota Solutions
11.19.1 Singota Solutions Company Details
11.19.2 Singota Solutions Business Overview
11.19.3 Singota Solutions Pharmaceutical Formulation Development Introduction
11.19.4 Singota Solutions Revenue in Pharmaceutical Formulation Development Business (2020-2025)
11.19.5 Singota Solutions Recent Development
11.20 Creative Biolabs
11.20.1 Creative Biolabs Company Details
11.20.2 Creative Biolabs Business Overview
11.20.3 Creative Biolabs Pharmaceutical Formulation Development Introduction
11.20.4 Creative Biolabs Revenue in Pharmaceutical Formulation Development Business (2020-2025)
11.20.5 Creative Biolabs Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
LGM Pharma
Dalton Pharma Services
Recipharm
Aurigene Pharmaceutical Services
Coriolis Pharma
Intertek
Quay Pharma
Lonza
Ardena
Kemwell
SGS
Syngene International
Piramal Pharma Solutions
Pharma Mo Ltd
Metrics Contract Services
COREALIS Pharma
Element Materials Technology
Adare Pharma Solutions
Singota Solutions
Creative Biolabs
听
听
*If Applicable.
